🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Hepatitis A Vaccine

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs NCT07069569Phase 214 sites📍 Beijing📍 Chongqing📍 Fuzhou Ausper Biopharma Co., Ltd. · Tests: AHB-137, Peg-IFN, Hepatitis B Vaccine TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site📍 Baltimore University of Maryland, Baltimore · Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine NCT03609398Phase 21 site📍 Fort Deterick U.S. Army Medical Research and Development Command · Tests: RVF Vaccine Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis NCT04588077Phase 41 site📍 Baltimore Mercy Medical Center · Tests: Heplisav-B Injectable Product, 2-dose regimen, Heplisav-B Injectable Product, 3-dose regimen Phase Ⅲ Clinical Trial of an Inactivated Hepatitis A Vaccine NCT07793227Phase 31 site📍 Hanoi Sinovac Biotech Co., Ltd · Tests: Inactivated Hepatitis A Vaccine (Human Diploid Cell) (1 mL), Inactivated Hepatitis A Vaccine (Human Diploid Cell) (0.5 … TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate NCT06513286Phase 1, Phase 26 sites📍 Frankfurt📍 Hamburg📍 Hanover Michael Hoelscher · Tests: TherVacB (HEPLISAV B +/- HBcoreAg + MVA-HBVac), TherVacB (2xHEPLISAV B + HBcoreAg + MVA-HBVac) Research on Clinical Recovery and Maintenance Strategies for CHB NCT06803368NA1 site📍 Beijing Beijing Municipal Administration of Hospitals · Tests: baseline anti-HBs titer The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort NCT04970836NA1 site📍 Taipei National Taiwan University Hospital · Tests: recombinant hepatitis B vaccine Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910n/a1 site📍 Phnom Penh Institut Pasteur du Cambodge Hepatitis B Vaccination After Neonatal Surgery NCT06023056n/a1 site📍 Chongqing Children's Hospital of Chongqing Medical University A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection NCT07051187Phase 11 site📍 Chengdu Jiyan Liu · Tests: WGc0201 Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A Vaccine NCT07889219n/a1 site📍 Changzhou Sinovac Biotech Co., Ltd · Tests: Healive®, Havrix®
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy